FDA Inspection
Lotte Biologics USA, LLCLotte Biologics USA, LLC – FDA Inspection, Apr 28, 2017
Record Details
This FDA Inspection record concerns Lotte Biologics USA, LLC, with an inspection on April 28, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9c925bd6-8450-4e25-bc7b-5ee740e84242
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1010187
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Lotte Biologics USA, LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2026 | Not classified | New York District Office | |
| September 19, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 5, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 20, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lotte Biologics USA, LLC
- FDA Inspection 1341414 - 2026-09-18
- FDA Inspection 1246771 - 2024-09-19
- FDA Inspection 1093554 - 2019-06-05
- FDA Inspection 897857 - 2014-09-25
- FDA Inspection 794472 - 2012-07-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.